Insmed | INSM - O Lucro Antes De Impostos





O Lucro Antes De Impostos Alterar Data
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Cytokinetics USD -183.03M 123.15M 2025-12
DBV Technologies USD -33.16M 8.6M 2025-09
Gilead Sciences USD 2.08B 1.56B 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
Insmed USD -326.93M 41.77M 2025-12
Novartis USD 5.17B 637M 2025-09
Regeneron Pharmaceuticals USD 1.04B 719.6M 2025-12
Sarepta Therapeutics USD -407.67M 213.63M 2025-12
Ultragenyx Pharmaceutical USD -184M 56M 2026-03
Vertex Pharmaceuticals USD 1.33B 32.2M 2025-12